Glioblastoma Brain Tumor: General Overview
Ian C. Langtree - Writer/Editor for Disabled World (DW)
Published: 2009/04/02 - Updated: 2023/01/28
Topic: Brain Cancer and Tumors - Publications List
Page Content: Synopsis - Introduction - Main
Synopsis: Glioblastoma Multiforme is a fast-growing type of central nervous system tumor that forms from glial tissue of the brain and spinal cord. Glioblastoma Multiforme (GBM) is composed of glial (supportive) brain cells that grow, divide and spread aggressively throughout the brain tissue, having lost their control mechanisms. Consequently, these tumors are difficult to treat and often recur after initial therapy.
Introduction
Glioblastoma Multiforme is a fast-growing type of central nervous system tumor that forms from the brain and spinal cord's glial (supportive) tissue and has cells that look very different from normal cells.
Alternate Names: Grades III and IV Astrocytoma, malignant glioma, anaplastic glioma, brain cancer, adult brain tumor, GBM.
The U.S. Social Security Administration (SSA) has included Glioblastoma Multiforme (Brain Tumor) as a Compassionate Allowance to expedite a disability claim.
Focus
Glioblastoma multiforme or grade IV astrocytoma is the most malignant of the primary brain tumors.
GBM is composed of glial (supportive) brain cells that grow, divide and spread aggressively throughout the brain tissue, having lost their control mechanisms. Consequently, these tumors are difficult to treat and often recur after initial therapy.
Glioblastoma multiforme most often occurs in adults between the ages of 45 and 70 years and affects the brain more often than the spinal cord.
The symptoms of glioblastoma multiforme may include; frequent headaches, vomiting, loss of appetite, changes in mood and personality, changes in the ability to think and learn, and seizures.
Diagnosis is based on patient history, neurological examination, and diagnostic procedures. The only definitive test that can provide a diagnosis of glioblastoma multiforme is a biopsy of the tumor.
Testing to confirm the diagnosis of glioblastoma multiforme includes neuroimaging (CT and MRI) to provide information about the tumor's location, size, and shape.
Treatment of glioblastoma multiforme may include the following: surgery, radiation and/or chemotherapy.
Glioblastoma multiforme is highly aggressive, infiltrating, and responds poorly to all currently available treatments. The prognosis is grim as most patients die within two years, and few survive longer than three years.
Author Credentials: Ian is an Australian-born writer, editor, and advocate who currently resides in Montreal, Canada. He is the founder and Editor-in-Chief of Disabled World, a leading resource for news and information on disability issues. With a global perspective shaped by years of travel and lived experience, Ian is a committed proponent of the Social Model of Disability-a transformative framework developed by disabled activists in the 1970s that emphasizes dismantling societal barriers rather than focusing solely on individual impairments. His work reflects a deep commitment to disability rights, accessibility, and social inclusion. To learn more about Ian's background, expertise, and accomplishments, visit his full biography.